HCAT Health Catalyst, Inc

XNAS 1.51 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

HCAT $1.51 —

What changed

Recent filings, trades and moves
Key stats
$1.51
52-Week Range
$0.96 – $3.36
YTD
-33.77%
IV Rank (30D)
47.57
Straddle Price
$0.75
P/C Vol Ratio
0.06
Market Cap
$0.1B
Open
$1.57
Day Range
$1.43 – $1.60
Volume
532,951
Prev Close
$1.46
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.90%
Beta vs SPY1.55
Cost of Equity (CAPM)13.42% (VRP-adj)
WACC8.67%
Volatility Risk Premium+179.1pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-7.6%
DCF Horizon5 years explicit + fade
Free Cash Flow (TTM)$0.0B
Return on Equity (TTM)-262.6%
Book / Price93.4% — banking bias active (P/B is primary)
Gross Margin (TTM)50.5%
FCF Margin (TTM)9.2%
Debt / Equity1.51
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$1.71 (Market Anchor value)
SMA 20 / Bollinger Mid$1.67
Bollinger Width / SMA2026.1% (drives anchor stability)
Net Debt$0.1B
Market Cap$0B
Peers used for multiples: FLUT, PINS, ZM (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$3.39
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF $2.61 40%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA $0.50 12% median 21.2× · 3 peers
Peer P/B $3.12 16% median 2.3× · 3 peers
Peer P/S $9.56 16% median 2.4× · 3 peers
Market Anchor (SMA50) $1.71 16% stability 20% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-11-09 · updated
About
Industry (SIC)
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. (7370) · industry map
Exchange
XNAS
Market Cap
$0.1B
Employees
1,200
List Date
2019-07-25
CIK
0001636422
Last Earnings
Nov 5 after close · −2.7% vs ±1333.3% expected
Headquarters
South Jordan, UT
Homepage
https://www.healthcatalyst.com

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to …

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan16.73%-25.99%33.78%7.13%-23.24%-5.70%0.45%
Feb-2.00%-10.94%1.01%-15.79%-14.63%-29.57%-11.99%
Mar-3.65%-1.62%-18.51%-6.58%-1.52%-24.40%-9.38%
Apr20.20%-39.78%6.15%-14.56%-8.78%7.76%-4.83%
May-7.34%-12.90%-13.25%5.07%-4.76%-4.83%-6.33%
Jun3.27%3.28%10.91%-0.62%-0.53%43.17%9.91%
Jul2.74%8.70%14.81%21.42%-9.88%1.21%6.50%
Aug-5.81%-29.37%-18.37%1.13%-3.69%-25.79%-13.65%
Sep-7.51%-17.66%-13.65%12.28%-16.18%1.17%-6.92%
Oct6.32%-14.04%-26.28%-3.48%14.95%-0.59%-3.85%
Nov-19.68%15.93%-0.69%14.68%-4.78%-4.43%*0.17%
Dec-3.79%-0.09%21.68%-21.62%-17.87%---4.34%
Total-6.78%-77.89%-18.92%-10.06%-63.53%-46.78%-37.33%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.66
SMA 50: $1.71
SMA 200: $1.69
Current: $1.51
EMA 12: $1.59
EMA 26: $1.65
MACD: -0.0639 | Signal: -0.0223
BEARISH
ADX (14): 15.81
RANGE
+DI: 21.58
−DI: 28.59

Momentum Oscillators

RSI (14): 41.60
NEUTRAL
Stoch %K: 17.90
Stoch %D: 19.63
Williams %R: -75.46

Volume & Volatility

BB Upper: $1.89
BB Lower: $1.43
NEUTRAL
OBV: -9,681,049
Vol SMA 20: 370,242
Vol ROC: 169.36%
ATR: $0.12
True Range: $0.17
HV 20: 86.5%
HV 30: 71.2%
HV 60: 64.5%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-11T00:00:00 – 2026-11-09T00:00:00
AI Analysis
Written before HCAT’s Nov 5 earnings report, so it doesn’t reflect the results.

Here is the stock analysis report for HCAT:

Executive Summary

  • Overall assessment: BEARISH (confidence level 6/10)
  • Key drivers: Negative earnings surprise, high volatility
  • Primary risks: Earnings miss, regulatory issues
  • Investment thesis: Sell on strength near SMA 20 and 50; target $1.70 for stop-loss
  • Recent news sentiment impact: Negative headline sentiment -37% (vs overall market)

Technical Analysis

  • Trend Direction: Short-term bearish, Medium-term neutral, Long-term bearish
  • Support/Resistance Levels: Key price levels from moving averages and technical patterns:
    • SMA 20: $2.06
    • SMA 50: $2.26
    • SMA 200: $3.08
  • Momentum Signals:
    • RSI (14): Neutral (33.32)
    • MACD: Bearish (-0.15 / Signal: -0.02 / Histogram: -0.12)
    • Bollinger Bands position: Neutral
  • Volume Analysis: Volume trends and institutional interest signals:
    • Volume SMA 20: 913870.45 (neutral)
    • On-Balance Volume (OBV): -24295931.00 (bearish)
    • Volume Rate of Change: -15.00% (bearish)

News & Sentiment Analysis

  • Recent Headlines Summary: Key themes from last 10 news articles:
    • Negative earnings surprise, regulatory issues
  • Sentiment Assessment: Aggregate news sentiment -37% (vs overall market)
  • Catalyst Identification: Upcoming events: Earnings release on March 15th
  • Market Narrative: News aligns with bearish technical signals

Risk & Volatility Assessment

  • Beta Interpretation: High risk relative to market (beta >1.5)
  • Volatility Regime: Current volatility is high (0.66) vs historical levels
  • Options Market Signals: IV rank: 98.5% (High), Put/Call volume ratio: 0.33 (Bullish sentiment)
  • Downside Protection: Support level at $1.70; consider stop-loss at this level

Market Context & Positioning

  • Sector Performance: Relative strength vs sector/market: Weak
  • Institutional Activity: Volume patterns suggesting institutional interest:
    • Institutional buying/selling signals are mixed
  • Correlation Analysis: How stock moves relative to market (R-squared interpretation):
    • Correlation: 0.41 (Moderate correlation)
  • Relative Valuation: Position within trading range:

Key Levels & Action Items

  • Critical Price Levels: Support/resistance levels:
    • SMA 20: $2.06
    • SMA 50: $2.26
    • SMA 200: $3.08
  • Breakout/Breakdown Levels: Technical levels that could trigger significant moves:
    • Above SMA 20: Bullish signal
    • Below SMA 50: Bearish signal
  • Time-Sensitive Catalysts: Earnings release on March 15th
  • Risk Management: Consider stop-loss at $1.70; adjust position sizing according to risk tolerance

This analysis highlights the bearish sentiment and high volatility in HCAT's recent performance, with negative earnings surprise and regulatory issues driving the stock lower. The technical signals are mostly bearish, but there is some bullish momentum from the MACD. Options market signals indicate a high IV rank and mixed institutional interest. Risk management considerations include setting a stop-loss at $1.70 and adjusting position sizing according to risk tolerance.

Generated
News
All HCAT news →
Earnings History
21 of 24 under expected move
Avg Expected Move
76.41%
Avg Actual Move
9.91%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-05-06 After-Close 9.52% 3.42% 0.36x Within
2021-08-05 After-Close 11.53% 0.21% 0.02x Within
2021-11-09 After-Close 2.36% 3.68% 1.56x Exceeded
2022-05-10 After-Close 5.71% 2.63% 0.46x Within
2022-08-04 After-Close 15.05% 37.88% 2.52x Exceeded
2022-11-08 After-Close 23.96% 23.34% 0.97x Within
2023-01-09 After-Close 3.34% 2.00% 0.60x Within
2023-02-28 After-Close 8.60% 2.58% 0.30x Within
2023-05-09 After-Close 11.80% 17.49% 1.48x Exceeded
2023-08-08 After-Close 42.70% 3.78% 0.09x Within
2023-10-27 After-Close 22.59% 4.81% 0.21x Within
2024-02-22 After-Close 17.71% 8.15% 0.46x Within
2024-05-09 After-Close 17.99% 3.90% 0.22x Within
2024-08-07 Pre-Market 19.39% 7.59% 0.39x Within
2024-11-06 After-Close 15.45% 7.39% 0.48x Within
2025-02-26 After-Close 20.24% 11.13% 0.55x Within
2025-05-07 After-Close 25.82% 5.29% 0.20x Within
2025-08-07 After-Close 33.88% 23.31% 0.69x Within
2025-11-10 After-Close 37.72% 5.61% 0.15x Within
2026-01-12 Pre-Market 7.09% 0.40% 0.06x Within
2026-03-12 After-Close 41.90% 26.26% 0.63x Within
2026-05-11 Pre-Market 58.58% 9.21% 0.16x Within
2026-08-06 After-Close 47.62% 25.11% 0.53x Within
2026-11-05 After-Close 1333.33% 2.67% 0.00x Within

Earnings calendar: this week’s reports with expected vs actual moves →

HCAT Options Activity & IV Rank

HCAT IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 211.2%
7-DTE IV: 254.6%
Expected Move: $0.75
7-DTE Move: $0.72
Days to Exp: 39 (2026-12-18)

Options Flow · All expiries

Call Volume: 415
Put Volume: 23
P/C Volume: 0.055
BULLISH
Call OI: 37,152
Put OI: 15,961
P/C OI: 0.43
Total OI: 53,113

ATM Options Pricing

ATM Call: $0.38
ATM Put: $0.38
Call %: 24.8%
Put %: 24.8%

Chain Summary

Chain Volume: 438
Chain OI: 53,113
Last Updated: 11/9/2026
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 35th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
35%
vs own history
GEX tilt
+0.98
OI-weighted, today
Vanna tilt
+0.98
δ-sensitivity to IV
Charm tilt
-0.99
δ-decay vs time
Vanna tilt +0.98: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.99: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 3 ATM contracts, 1k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)45.2MediumNov 9
IV Rank (30 DTE)47.6MediumNov 9

Embed HCAT IV rank

HCAT's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview
Straddle Price (30 DTE)$0.75Nov 9
Beta Analysis

Risk Metrics

Beta: 1.3753
Alpha: -39.48%
Correlation: 0.2058
R-Squared: 4.2%
Stock Volatility: 91.9%
Market Volatility: 13.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own HCAT
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$1.0M
0.00%
#2891 of 3716new13F
Citadel Hedge fund
Ken Griffin
$902K
0.00%
#3814 of 6285new13F
Renaissance Technologies Hedge fund
Jim Simons
$695K
0.00%
#2475 of 3138+60.9%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

HCAT Institutional Ownership (13F)

Filings for 2026-06-30 · 39 already for 2026-09-30
Diluted shares outstanding: 71,706,480 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

119 filers51,940,262 shares$101.91M value72.43% of float
# Filer Shares Value % of Total % of Float Period
1 First Light Asset Management, LLC 12,810,861 $25.49M 25.02% 17.87% 2026-06-30
2 CDC Financial, Inc. 7,092,698 $14.11M 13.85% 9.89% 2026-06-30
3 Palogic Value Management, L.P. 4,922,442 $9.80M 9.61% 6.86% 2026-06-30
4 Impax Asset Management Group plc 4,000,000 $7.96M 7.81% 5.58% 2026-06-30
5 Vanguard Capital Management LLC 2,971,598 $5.91M 5.80% 4.14% 2026-06-30
6 Nepsis Inc. 2,989,705 $5.17M 5.08% 4.17% 2026-09-30
7 BlackRock, Inc. Custodian 1,836,373 $3.65M 3.59% 2.56% 2026-06-30
8 HRT FINANCIAL LP 1,127,015 $2.24M 2.20% 1.57% 2026-06-30
9 Jane Street Group, LLC Custodian 1,037,782 $2.07M 2.03% 1.45% 2026-06-30
10 HighMark Wealth Management LLC 871,082 $1.73M 1.70% 1.21% 2026-06-30
11 Caption Management, LLC 773,650 $1.54M 1.51% 1.08% 2026-06-30
12 Mink Brook Asset Management LLC 738,277 $1.47M 1.44% 1.03% 2026-06-30
13 Geode Capital Management, LLC Custodian 793,949 $1.37M 1.35% 1.11% 2026-09-30
14 Prescott Group Capital Management, L.L.C. 710,803 $1.23M 1.21% 0.99% 2026-09-30
15 Charles Schwab Investment Management, Inc. 615,504 $1.22M 1.20% 0.86% 2026-06-30
16 Millennium Management LLC Custodian 516,083 $1.03M 1.01% 0.72% 2026-06-30
17 Goldman Sachs Group Inc Custodian 480,970 $957.13K 0.94% 0.67% 2026-06-30
18 Vanguard Fiduciary Trust Co 463,005 $921.38K 0.90% 0.65% 2026-06-30
19 Citadel Advisors LLC Custodian 453,214 $901.90K 0.89% 0.63% 2026-06-30
20 Susquehanna International Group, LLP Custodian 437,227 $870.08K 0.85% 0.61% 2026-06-30
21 FMR LLC Custodian 410,637 $817.17K 0.80% 0.57% 2026-06-30
22 HSBC Holdings plc Custodian 408,634 $809.10K 0.79% 0.57% 2026-06-30
23 Squarepoint Ops LLC 400,210 $796.42K 0.78% 0.56% 2026-06-30
24 AQR Capital Management, LLC Custodian 376,586 $749.41K 0.74% 0.53% 2026-06-30
25 State Street Corp 360,713 $717.82K 0.70% 0.50% 2026-06-30
8 filers$5.98M notional
# Filer Notional Value % of Total Period
1 Whetstone Capital Advisors, LLC $3.01M 50.43% 2026-06-30
2 Caption Management, LLC $1.69M 28.29% 2026-06-30
3 PEAK6 LLC $995.00K 16.64% 2026-06-30
4 SIG BROKERAGE, LP $129.35K 2.16% 2026-06-30
5 Citadel Advisors LLC Custodian $75.02K 1.25% 2026-06-30
6 Susquehanna International Group, LLP Custodian $70.45K 1.18% 2026-06-30
7 GROUP ONE TRADING LLC Custodian $1.59K 0.03% 2026-06-30
8 Simplex Trading, LLC Custodian $692 0.01% 2026-09-30
7 filers$2.08M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $1.69M 81.22% 2026-06-30
2 SIG BROKERAGE, LP $129.35K 6.21% 2026-06-30
3 Citadel Advisors LLC Custodian $111.04K 5.33% 2026-06-30
4 Susquehanna International Group, LLP Custodian $108.65K 5.22% 2026-06-30
5 IMC-Chicago, LLC Custodian $25.43K 1.22% 2026-09-30
6 Simplex Trading, LLC Custodian $15.57K 0.75% 2026-09-30
7 GROUP ONE TRADING LLC Custodian $1.19K 0.06% 2026-06-30

HCAT Insider Trading (Form 4)

Latest: 2026-10-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-05 Tami Reller Director Award (A) +128,851 — EDGAR
2026-09-16 Simeon Kohl Chief Executive Officer Mixed
Grant +2,747,385 · Buy +59,000
 +2,806,385 $1.79 $105.4K EDGAR
2026-09-11 Benjamin Albert CEO Tax (F) −35,244 $1.67 -$59.0K EDGAR
2026-09-03 Julie Larson-Green Director Award (A) +9,766 — EDGAR
2026-09-03 Benjamin Landry General Counsel Tax (F) −13,167 $1.70 -$22.4K EDGAR
2026-09-03 Jason Alger Chief Financial Officer Tax (F) −17,973 $1.70 -$30.6K EDGAR
2026-09-03 Benjamin Albert CEO Tax (F) −321 $1.70 -$547 EDGAR
2026-07-20 Julie Larson-Green Director Award (A) +80,691 — EDGAR
2026-07-20 Justin Spencer Director Award (A) +80,691 — EDGAR
2026-07-20 Steven H Nelson Director Award (A) +80,691 — EDGAR
2026-07-20 Green Jill Hoggard Director Award (A) +80,691 — EDGAR
2026-06-15 Benjamin Albert CEO Tax (F) −34,485 $1.69 -$58.3K EDGAR
2026-06-03 Jason Alger Chief Financial Officer Tax (F) −18,804 $1.37 -$25.8K EDGAR
2026-06-03 Benjamin Albert CEO Tax (F) −336 $1.37 -$460 EDGAR
2026-06-03 Benjamin Landry General Counsel Tax (F) −13,779 $1.37 -$18.9K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

HCAT Insider Holdings

18 insiders · @ $1.51
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Simeon Kohl Chief Executive Officer 2,856,385 $4.31M $105.4K 1 2026-09-16
2 Daniel D. Burton Chief Executive Officer 1,393,099 $2.10M -$44.06M 43 2025-12-03
3 Benjamin Albert CEO 1,388,406 $2.10M $0 9 2026-09-11
4 Jason Alger Chief Financial Officer 704,867 $1.06M -$776.4K 44 2026-09-03
5 Kevin Lee Freeman Chief Commercial Officer 358,686 $541.6K -$170.3K 17 2025-12-03
6 Benjamin Landry General Counsel 351,372 $530.6K -$515.5K 29 2026-09-03
7 Linda Llewelyn Chief People Officer 321,132 $484.9K -$3.73M 87 2026-06-03
8 Steven H Nelson Director 235,499 $355.6K $0 2 2026-07-20
9 David Coy Ross Chief Tech & Product Officer 204,219 $308.4K $0 1 2025-09-04
10 Daniel LeSueur Chief Operating Officer 198,367 $299.5K -$649.8K 19 2025-09-04
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

HCAT Board & Officers

As of SEC filings through Oct 5, 2026

Directors 9

Officers 4

10% owners 2

Changes in the last 10 years (84)
Oct 1, 2026Tami Reller became a director
Sep 14, 2026Simeon Kohl became a director
Sep 14, 2026Simeon Kohl became Chief Executive Officer
Sep 4, 2026The company announced the departure of Benjamin Albert as CEO in an SEC filing
Jun 3, 2026Linda Llewelyn reported in an SEC filing no longer being Chief People Officer
May 1, 2026Steven H Nelson became a director
Feb 27, 2026Benjamin Albert listed as CEO (previously President and COO) in SEC filings
Feb 27, 2026Benjamin Albert first listed as a director in an SEC filing
Feb 12, 2026The company announced the departure of S. Dawn Smith from the board in an SEC filing
Feb 12, 2026The company announced the departure of John A Kane from the board in an SEC filing
Feb 12, 2026The company announced the departure of Duncan Gallagher from the board in an SEC filing
Jan 20, 2026The company announced the departure of Kevin Lee Freeman as Chief Commercial Officer in an SEC filing
Dec 1, 2025Mathew Paul Arens became a director
Dec 1, 2025Mathew Paul Arens became a 10% owner
Dec 1, 2025First Light Asset Management, LLC became a 10% owner
Sep 16, 2025Benjamin Albert became President and COO
Sep 10, 2025The company announced the departure of Daniel LeSueur as Chief Operating Officer in an SEC filing
Sep 1, 2025Justin Spencer became a director
Aug 5, 2025The company announced the departure of Daniel D. Burton as Chief Executive Officer in an SEC filing
Jun 15, 2025David Coy Ross became Chief Tech & Product Officer
Not reported recently (8)
  • Anne Marie Bickmore · Last reported as COO and Chief Product Officer in an SEC filing dated Dec 5, 2023
  • Matthew Kolb · Last reported as a director in an SEC filing dated Jul 11, 2023
  • Bryan Richard Hinton · Last reported as Chief Technology Officer in an SEC filing dated Sep 6, 2022
  • D Fraser Bullock · Last reported as a director in an SEC filing dated Jun 14, 2021
  • Timothy G. Ferris · Last reported as a director in an SEC filing dated Jan 13, 2021
  • Dale Sanders · Last reported as Chief Technology Officer in an SEC filing dated Sep 3, 2020
  • Michael Edward Dixon · Last reported as a director in an SEC filing dated Jun 17, 2020
  • Todd C Cozzens · Last reported as a director in an SEC filing dated Jun 17, 2020
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

HCAT Proposed Insider Sales (Form 144)

Latest: 2026-09-10
Last 30d: 0 filings  ·  Last 90d: 4 filings · $113K notice value · 3 unique filers

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Benjamin Albert (2, $60K) · Jason Alger (1, $31K) · Benjamin Landry (1, $22K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-09-10 Benjamin Albert Officer 35,244 $59.0K 2026-09-10 Morgan Stanley Smith Barney LLC — EDGAR
2026-09-01 Benjamin Albert Officer 321 $547 2026-09-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-09-01 Jason Alger Officer 17,973 $30.6K 2026-09-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-09-01 Benjamin Landry Officer 13,167 $22.4K 2026-09-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-06-10 Benjamin Albert Officer 34,485 $58.3K 2026-06-10 Morgan Stanley Smith Barney LLC — EDGAR
2026-06-01 Benjamin Albert Officer 336 $460 2026-06-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-06-01 Jason Alger Officer 18,804 $25.8K 2026-06-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-06-01 Linda Llewelyn Officer 8,519 $11.7K 2026-06-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-06-01 Benjamin Landry Officer 13,779 $18.9K 2026-06-01 Morgan Stanley Smith Barney LLC — EDGAR
2026-05-01 Benjamin Albert Officer 310 $417 2026-05-01 Morgan Stanley Smith Barney LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-05 Earnings results EDGAR
2026-09-14 Director or officer change · Regulation FD disclosure EDGAR
2026-09-08 Director or officer change · Regulation FD disclosure EDGAR
2026-08-06 Agreement terminated · Acquisition or sale completed · Earnings results · Regulation FD disclosure EDGAR
2026-07-20 Shareholder vote results EDGAR
2026-06-04 Material agreement · Regulation FD disclosure EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-05 0001636422-26-000125 EDGAR
2026-08-06 0001636422-26-000097 EDGAR
ETF Holders
10 ETFs hold HCAT
10 shown · $6.82M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $3.6M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $1.1M — 2026-09-30
3 FESM Fidelity Enhanced Small Cap Core ETF Fidelity 0.01% $732,100 $6.6B 2026-11-05
4 SCHA Schwab U.S. Small-Cap ETF Nport 0.00% $563,971 — 2026-08-31
5 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.02% $265,076 $1.2B 2026-11-06
6 VHT Vanguard Health Care ETF Vanguard 0.00% $237,991 — 2026-09-30
7 SCHB Schwab U.S. Broad Market ETF Nport 0.00% $181,035 — 2026-08-31
8 EES WisdomTree U.S. SmallCap Fund Nport 0.02% $117,967 — 2026-06-30
9 PRFZ Invesco RAFI US 1500 Small-Mid ETF Nport 0.00% $77,618 — 2026-07-31
10 AVUV Avantis U.S. Small Cap Value ETF Avantis 0.00% $5,910 $31.6B 2026-11-05
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-3.70
TTM Revenue
$292.25M
TTM Net Income
$-264.82M
TTM Op. Cash Flow
$28.23M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$70.49M$-40.54M$-0.55$275.00K
Q1 '262026-03-31$70.76M$-111.03M$-1.53$18.51M
Q4 '252025-12-31$74.68M$-91.03M$-1.30$9.91M
Q3 '252025-09-30$76.32M$-22.23M$-0.32$-464.00K
Q2 '252025-06-30$80.72M$-40.98M$-0.59$-9.00M
Q1 '252025-03-31$79.41M$-23.74M$-0.35$280.00K
Q4 '242024-12-31$79.61M$-20.67M$-0.33$-3.53M
Q3 '242024-09-30$76.35M$-14.73M$-0.24$6.21M
Q2 '242024-06-30$75.90M$-13.52M$-0.23$1.61M
Q1 '242024-03-31$74.72M$-20.59M$-0.35$10.27M
Q4 '232023-12-31$75.08M$-30.31M$-0.52$-19.04M
Q3 '232023-09-30$73.77M$-22.03M$-0.39$3.12M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-06
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.07
P/S
0.37
EV/EBITDA
33.00
EV/Sales
0.68
ROE
-262.6%
ROA
-73.8%
Div Yield
0.00%
FCF Yield
26.08%
Debt/Equity
1.51
Current Ratio
—
Market Cap
$108.28M
as of 2026-11-09

HCAT vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
LLY Eli Lilly & Co. $1.21T 45.8 +45.5% +30.7% 27
JNJ Johnson & Johnson $664.9B 42.8 +7.8% +36.1% 54
ABBV ABBVIE INC. $514.9B 50.5 +10.7% +27.9% 30
MRK Merck & Co., Inc. $361.7B 153.4 +4.9% +39.7% 44
UNH UNITEDHEALTH GROUP INCORPORATED (Delawar $353.2B 30.0 +9.7% +18.2% 40
TMO Thermo Fisher Scientific, Inc. $257.4B 38.1 +8.3% +21.8% 42
AMGN Amgen Inc $249.0B 27.0 +8.2% +42.0% 32
VEEV Veeva Systems Inc. $49.2B 50.1 +16.5% +39.6% 68
HCAT Health Catalyst, Inc Common Stock $111M — −7.5% −33.8% 48
Peer median $357.4B 44.3 +9.0% +33.4% 41

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.07M
SI % of Float
3.55%
Days to Cover
4.36
Short Vol Ratio
40.4%
Free Float
58.32M
Float %
77.5%
Short interest 2026-10-15 • Short volume 2026-11-09 • Float 2026-09-09